JP2018138049A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018138049A5 JP2018138049A5 JP2018088729A JP2018088729A JP2018138049A5 JP 2018138049 A5 JP2018138049 A5 JP 2018138049A5 JP 2018088729 A JP2018088729 A JP 2018088729A JP 2018088729 A JP2018088729 A JP 2018088729A JP 2018138049 A5 JP2018138049 A5 JP 2018138049A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- amino acid
- acid sequence
- seq
- nos
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011098270 | 2011-04-26 | ||
| JP2011098270 | 2011-04-26 | ||
| JP2011219454 | 2011-10-03 | ||
| JP2011219454 | 2011-10-03 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016214996A Division JP6336549B2 (ja) | 2011-04-26 | 2016-11-02 | 組織再生を誘導するためのペプチドとその利用 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019175276A Division JP2020058344A (ja) | 2011-04-26 | 2019-09-26 | 組織再生を誘導するためのペプチドとその利用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018138049A JP2018138049A (ja) | 2018-09-06 |
| JP2018138049A5 true JP2018138049A5 (enExample) | 2018-12-13 |
| JP6603964B2 JP6603964B2 (ja) | 2019-11-13 |
Family
ID=47071995
Family Applications (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013511983A Active JP6069191B2 (ja) | 2011-04-26 | 2012-04-03 | 組織再生を誘導するためのペプチドとその利用 |
| JP2016214996A Active JP6336549B2 (ja) | 2011-04-26 | 2016-11-02 | 組織再生を誘導するためのペプチドとその利用 |
| JP2018088729A Active JP6603964B2 (ja) | 2011-04-26 | 2018-05-02 | 組織再生を誘導するためのペプチドとその利用 |
| JP2019175276A Pending JP2020058344A (ja) | 2011-04-26 | 2019-09-26 | 組織再生を誘導するためのペプチドとその利用 |
| JP2021129955A Pending JP2021191271A (ja) | 2011-04-26 | 2021-08-06 | 組織再生を誘導するためのペプチドとその利用 |
| JP2023084251A Pending JP2023106525A (ja) | 2011-04-26 | 2023-05-23 | 組織再生を誘導するためのペプチドとその利用 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013511983A Active JP6069191B2 (ja) | 2011-04-26 | 2012-04-03 | 組織再生を誘導するためのペプチドとその利用 |
| JP2016214996A Active JP6336549B2 (ja) | 2011-04-26 | 2016-11-02 | 組織再生を誘導するためのペプチドとその利用 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019175276A Pending JP2020058344A (ja) | 2011-04-26 | 2019-09-26 | 組織再生を誘導するためのペプチドとその利用 |
| JP2021129955A Pending JP2021191271A (ja) | 2011-04-26 | 2021-08-06 | 組織再生を誘導するためのペプチドとその利用 |
| JP2023084251A Pending JP2023106525A (ja) | 2011-04-26 | 2023-05-23 | 組織再生を誘導するためのペプチドとその利用 |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US10364276B2 (enExample) |
| EP (2) | EP3358011B1 (enExample) |
| JP (6) | JP6069191B2 (enExample) |
| KR (2) | KR101992807B1 (enExample) |
| CN (3) | CN107188948B (enExample) |
| AU (4) | AU2012248676B2 (enExample) |
| CA (1) | CA2834255C (enExample) |
| DK (2) | DK2703487T3 (enExample) |
| ES (2) | ES2788394T3 (enExample) |
| PL (2) | PL2703487T3 (enExample) |
| PT (2) | PT2703487T (enExample) |
| WO (1) | WO2012147470A1 (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009133943A1 (ja) | 2008-04-30 | 2009-11-05 | 株式会社ジェノミックス | 生体内機能的細胞の高効率採取法 |
| KR20120135190A (ko) | 2009-10-28 | 2012-12-12 | 고꾸리쯔 다이가꾸 호우징 오사까 다이가꾸 | 골수 간엽계 및/또는 다능성 줄기세포의 혈중 동원(動員)에 의한 조직 재생 촉진제 |
| DK2913059T3 (en) | 2012-10-25 | 2018-06-25 | Genomix Co Ltd | Hitherto UNKNOWN PROCEDURE FOR TREATMENT OF SPINE INJURY USING HMGB1 FRAGMENT |
| JP6253589B2 (ja) | 2012-10-25 | 2017-12-27 | 株式会社ジェノミックス | Ｈｍｇｂ１断片を利用した新規心筋梗塞の治療法 |
| AU2014275130B2 (en) * | 2013-06-05 | 2019-09-12 | Reverse Bioengineering, Inc. | Compositions and methods for induced tissue regeneration in mammalian species |
| CA2984629C (en) | 2015-05-07 | 2024-06-18 | University Of South Florida | Modified ube3a gene for a gene therapy approach for angelman syndrome |
| CN115433707A (zh) | 2015-12-07 | 2022-12-06 | 再生疗法有限公司 | 用于重新衍生不同的多能干细胞衍生的褐色脂肪细胞的方法 |
| CN106995796A (zh) * | 2016-01-26 | 2017-08-01 | 李建业 | 基于细胞因子的细胞处理方法、试剂盒及冻干粉 |
| JP2019523633A (ja) * | 2016-04-29 | 2019-08-29 | アライム ファーマシューティカルズ，インコーポレーテッド | 組織の損傷に関連した疾患及び障害を予防及び治療する組織保護ペプチド |
| JP2019528753A (ja) * | 2016-09-21 | 2019-10-17 | スティーブン エイチ． ソーン， | 高移動度グループｂｏｘｉ突然変異体 |
| AU2018213671B2 (en) | 2017-01-27 | 2024-06-06 | Osaka University | Therapeutic agent for cardiomyopathy, old myocardial infarction and chronic heart failure |
| JPWO2018186480A1 (ja) | 2017-04-07 | 2020-02-20 | 株式会社ステムリム | 線維性疾患の治療薬 |
| MX2019012738A (es) * | 2017-04-25 | 2020-02-07 | Shionogi & Co | Peptido para inducir la regeneracion de tejido, y uso del mismo. |
| AU2018376452A1 (en) | 2017-12-01 | 2020-06-25 | Osaka University | Ectodermal mesenchymal stem cells and method for producing same |
| EP3718561A4 (en) | 2017-12-01 | 2021-07-21 | Stemrim Inc. | Therapy for inflammatory bowel disease |
| US20210024594A1 (en) | 2018-02-08 | 2021-01-28 | StemRIM Inc. | Therapeutic Agent for Psoriasis |
| WO2020071520A1 (ja) | 2018-10-05 | 2020-04-09 | 株式会社ステムリム | 間葉系幹細胞の動員活性を有するペプチド |
| US12304933B2 (en) | 2018-10-05 | 2025-05-20 | StemRIM Inc. | Disease treatment drug based on mesenchymal-stem-cell mobilization |
| ES3041501T3 (en) * | 2018-10-25 | 2025-11-12 | The Univ Of Osaka | Hmgb1 derived peptide for treating or preventing a cartilage disorder |
| US12678511B2 (en) | 2019-03-26 | 2026-07-14 | Kansai Medical University Educational Corporation | Peptide and use thereof |
| CN109957015A (zh) * | 2019-04-01 | 2019-07-02 | 中国人民解放军海军军医大学国家肝癌科学中心 | 一种hmgb1封闭性抗体的制备方法及其应用 |
| US12624074B2 (en) | 2019-11-12 | 2026-05-12 | Oxford University Innovation Limited | Polypeptides related to HMGB1 useful for promoting tissue regeneration, compositions comprising same, and uses thereof |
| JP7805925B2 (ja) * | 2019-11-12 | 2026-01-26 | オックスフォード ユニバーシティ イノベーション リミテッド | 組織再生の促進に有用なｈｍｇｂ１に関連するポリペプチド、それを含む組成物、及びその使用 |
| IL296982B2 (en) * | 2020-04-03 | 2026-04-01 | Stemrim Inc | Peptide having mesenchymal stem cell mobilizing activity |
| EP4147711A4 (en) * | 2020-04-20 | 2024-04-24 | Shionogi & Co., Ltd | FORMULATION WITH A HMGB1 PARTIAL PEPTIDE |
| WO2021242180A1 (en) * | 2020-04-22 | 2021-12-02 | Chulalongkorn University | A composition and a method of rejuvenating dna and preventing dna damage |
| JP2023552808A (ja) * | 2020-12-07 | 2023-12-19 | サムスン ライフ パブリック ウェルフェア ファウンデーション | 自己維持能が向上された間葉系幹細胞を選別する方法、及びそれによって選別された間葉系幹細胞 |
| WO2022243932A1 (en) * | 2021-05-19 | 2022-11-24 | Oxford University Innovation Limited | Polypeptides related to hmgb1 useful for promoting tissue regeneration, compositions comprising same, and uses thereof |
| KR20240070640A (ko) | 2021-09-30 | 2024-05-21 | 고꾸리쯔 다이가꾸 호우징 오사까 다이가꾸 | 지방간 및 비알코올성 지방간염의 치료약 |
| CN116983471B (zh) * | 2023-06-07 | 2024-03-08 | 华中科技大学同济医学院附属协和医院 | 一种基于α-螺旋双亲性多肽的超分子共组装凝胶的制备方法及应用 |
Family Cites Families (66)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5238680B2 (enExample) | 1972-12-27 | 1977-09-30 | ||
| US4732155A (en) | 1985-08-27 | 1988-03-22 | The Children's Medical Center Corporation | Implantable chemoattractant system |
| US5658894A (en) | 1989-04-23 | 1997-08-19 | The Trustees Of The University Of Pennsylvania | Compositions for inhibiting restenosis |
| US5661127A (en) | 1995-05-01 | 1997-08-26 | The Regents Of The University Of California | Peptide compositions with growth factor-like activity |
| JP3018313B2 (ja) | 1996-02-23 | 2000-03-13 | 雪印乳業株式会社 | 骨形成促進及び骨吸収防止剤 |
| US20040031072A1 (en) * | 1999-05-06 | 2004-02-12 | La Rosa Thomas J. | Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement |
| US6720340B1 (en) | 1999-07-28 | 2004-04-13 | The Board Of Trustees Of The Leland Stanford Jr. University | Nicotine receptor agonists in stem cell and progenitor cell recruitment |
| BR0015367A (pt) | 1999-11-05 | 2002-07-23 | Gerigene Medical Corp | Aumento e reparo de defeitos nos tecidos moles relacionados com a idade |
| EP1114862A3 (de) | 1999-11-17 | 2003-08-06 | Switch Biotech Aktiengesellschaft | Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankungen sowie ihre Verwendung zur Identifizierung von pharmakologisch aktiven Substanzen |
| HK1052372A1 (zh) | 2000-02-24 | 2003-09-11 | Xcyte Therapies, Inc. | 细胞的同步刺激和富集 |
| JP3421741B2 (ja) | 2000-05-18 | 2003-06-30 | 筑波大学長 | 人工骨髄、血球細胞の増殖方法 |
| US20040191246A1 (en) | 2003-02-26 | 2004-09-30 | Connelly Patrick R. | Process for in vivo treatment of specific biological targets in bodily fluid |
| ITMI20010562A1 (it) | 2001-03-16 | 2002-09-16 | Marco E Bianchi | Inibitori o antagonisti della proteina hmg1 per il trattamento di disordini vascolari |
| EP1390058A2 (en) | 2001-04-30 | 2004-02-25 | Switch Biotech Aktiengesellschaft | Mrp8/mrp14 heterodimer, or its individual components in combination, for treating and/or preventing skin diseases, wounds and/or wound-healing disturbances |
| DE10121254A1 (de) | 2001-04-30 | 2002-11-07 | Switch Biotech Ag | MRP8/MRP14 Heterodimers oder seiner Einzelkomponenten alleine oder in Kombination zur Behandlung und/oder Prävention von Hauterkrankungen, Wunden und/oder Wundheilungsstörungen, die durch eine verringerte Menge an MRP8/MRP14 Heterodimeren gekennzeichnet sind |
| BR0209689A (pt) | 2001-05-15 | 2006-02-07 | Long Island Jewish Res Inst | Uso de fragmento de hmg como agente anti-inflamatório |
| US7220723B2 (en) | 2001-05-15 | 2007-05-22 | The Feinstein Institute For Medical Research | Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents |
| US7304034B2 (en) | 2001-05-15 | 2007-12-04 | The Feinstein Institute For Medical Research | Use of HMGB fragments as anti-inflammatory agents |
| ITMI20011986A1 (it) | 2001-09-25 | 2003-03-25 | San Raffaele Centro Fond | Metodo e composizione per l'attivazione di cellule presentanti l'antigene |
| KR100704158B1 (ko) | 2001-11-19 | 2007-04-05 | 교와 핫꼬 고교 가부시끼가이샤 | 다분화능 줄기세포를 조직으로부터 말초혈로 동원하는약제 |
| CA2469370C (en) | 2001-12-07 | 2014-07-08 | Macropore Biosurgery, Inc. | Adipose-derived cell processing unit |
| FR2833609B1 (fr) | 2001-12-19 | 2004-12-03 | Natural Implant | Dispositif de prelevement cellulaire ou tissulaire en phase active et utilisations |
| DE60326453D1 (de) * | 2002-07-03 | 2009-04-16 | Ct Cardiologico Monzino S P A | Die verwendung von hmgb1 zur behandlung von gewebeverletzungen und/oder zur unterstützung der gewebewiederherstellung |
| US7553488B2 (en) | 2002-07-05 | 2009-06-30 | UNIVERSITé LAVAL | Antibodies against S100A8 and S100A9 proteins for modulating inflammatory reactions |
| GB0226251D0 (en) | 2002-11-11 | 2002-12-18 | San Raffaele Centro Fond | Acetylated protein |
| US20040156851A1 (en) | 2002-11-20 | 2004-08-12 | Critical Therapeutics, Inc. | HMGB1 combination therapies |
| JP2006510619A (ja) | 2002-11-20 | 2006-03-30 | クリティカル セラピューティクス，インコーポレイテッド | 抗炎症剤としてのｈｍｇｂ断片の使用 |
| EP1579221A2 (de) | 2003-01-03 | 2005-09-28 | Alcedo Biotech GmbH | Verwendungen von hmgb, hmgn, hmga proteinen |
| WO2004084928A1 (en) | 2003-03-28 | 2004-10-07 | UNIVERSITé LAVAL | S100 protein as neutrophil activator for alleviating neutropenia in cancer treatment |
| CN1193092C (zh) | 2003-03-28 | 2005-03-16 | 浙江大学 | 骨髓间充质干细胞分离和体外扩增培养方法 |
| US20090069227A9 (en) | 2003-04-29 | 2009-03-12 | Capogrossi Maurizio C | Use of HMGB1 to promote stem cell migration and/or proliferation |
| US20050014255A1 (en) | 2003-05-29 | 2005-01-20 | Board Of Regents, The University Of Texas System | Stem cells for clinical and commercial uses |
| WO2005025604A2 (en) | 2003-09-10 | 2005-03-24 | The General Hospital Corporation | Use of hmgb and hmgb fragments to decrease specific immune response |
| AU2004272607B2 (en) | 2003-09-11 | 2008-11-06 | Cornerstone Therapeutics Inc. | Monoclonal antibodies against HMGB1 |
| ITRM20040058A1 (it) | 2004-02-03 | 2004-05-03 | Marco E Bianchi | Inibitori ed antagonisti di hmgb1 in grado di regolare la proliferazione delle cellule muscolari lisce ed endoteliali. |
| US20090062187A1 (en) | 2004-07-20 | 2009-03-05 | Marco Bianchi | Use of Hmgb1 for Wound Healing |
| MX2007001155A (es) | 2004-07-29 | 2007-08-14 | Creabilis Therapeutics Spa | Uso de inhibidores de k-252a y de quinasa para la prevencion o el tratamiento de patologias asociadas con hmgb1. |
| CA2579094C (en) * | 2004-09-03 | 2014-12-02 | Creabilis Therapeutics S.P.A. | Use of polypeptides obtained through systematic mutations of single amino acids of human and non-human box-a of hmgb1 to prevent and/or antagonize pathologies induced by hmgb1 |
| JP2008520552A (ja) * | 2004-10-22 | 2008-06-19 | メディミューン，インコーポレーテッド | Ｈｍｇｂ１に対する高親和性の抗体およびその使用法 |
| KR100593397B1 (ko) | 2004-10-27 | 2006-06-28 | 한국원자력연구소 | 중배엽 줄기세포 및/또는 ｐ 물질을 함유하는 상처 치유또는 상처 치유 촉진제, 또는 세포 치료제 |
| WO2006047820A1 (en) | 2004-11-01 | 2006-05-11 | Newsouth Innovations Pty Limited | Use of calgranulin a and b in the promotion and inhibition of mineralized tissue formation |
| ITRM20050032A1 (it) | 2005-01-21 | 2006-07-22 | Marco E Bianchi | Inibitori ed antagonisti di hmgb1 in grado di inibire la patogenesi e la progressione della malattia aterosclerotica. |
| WO2006080434A1 (ja) | 2005-01-27 | 2006-08-03 | Japan Health Sciences Foundation | 間葉系幹細胞を含む細胞シート |
| US20080171951A1 (en) | 2005-03-23 | 2008-07-17 | Claude Fell | Integrated System for Collecting, Processing and Transplanting Cell Subsets, Including Adult Stem Cells, for Regenerative Medicine |
| KR100775958B1 (ko) * | 2005-03-30 | 2007-11-13 | 김정문 | 조직재생 기능을 가지는 비활성 폴리펩티드 및 그 제조방법 |
| WO2006114805A2 (en) | 2005-04-28 | 2006-11-02 | Fondazione Centro San Raffaele Del Monte Tabor | Use of hmgb2 and hmgb3 proteins for medical applications |
| US20100280493A1 (en) | 2005-06-23 | 2010-11-04 | Asha Nayak | Methods and Systems for Treating Injured Cardiac Tissue |
| WO2007015546A1 (ja) | 2005-08-04 | 2007-02-08 | Genomix Co., Ltd | 間葉系幹細胞誘導剤及び組織再生促進剤並びに間葉系幹細胞の調製方法 |
| WO2007031100A1 (en) | 2005-09-14 | 2007-03-22 | Ostini, Marco | Active immunotherapy of life-threatening systemic inflammation |
| WO2007061762A2 (en) * | 2005-11-18 | 2007-05-31 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Healt And Human Services | Non-viral gene delivery complex |
| WO2007130725A2 (en) | 2006-02-06 | 2007-11-15 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Use of hmgb1 for protection against ischemia reperfusion injury |
| JP4982739B2 (ja) | 2006-06-01 | 2012-07-25 | 国立大学法人 東京医科歯科大学 | ポリグルタミン病の予防・治療剤 |
| JP5244785B2 (ja) | 2006-08-11 | 2013-07-24 | 小野薬品工業株式会社 | ストローマ由来因子−１（ｓｄｆ−１）に対するモノクローナル抗体 |
| JP2010503630A (ja) | 2006-09-15 | 2010-02-04 | クレアビリス・セラピューティクス・エスピーエー | ＨＭＧＢ１のＢｏｘ−ＡおよびＨＭＧＢ１のＢｏｘ−Ａ変異体のポリマー複合体 |
| DK2068935T3 (da) * | 2006-09-15 | 2011-08-01 | Creabilis Therapeutics S R L | Polymerkonjugater af box-A af HMBG1 og boks-A-varianter af HMBG1 |
| CA2636788A1 (en) | 2006-10-30 | 2008-05-08 | Genomix Co., Ltd. | Hmgb protein for use in promoting tissue regeneration |
| CA2629652A1 (en) | 2007-04-24 | 2008-10-24 | Yaojiong Wu | Compositions for preventing or treating skin defects and methods of use thereof |
| US8114668B2 (en) | 2007-05-14 | 2012-02-14 | Cardiac Pacemakers, Inc. | Composition for cold storage of stem cells |
| WO2009133943A1 (ja) * | 2008-04-30 | 2009-11-05 | 株式会社ジェノミックス | 生体内機能的細胞の高効率採取法 |
| JP5660889B2 (ja) | 2008-04-30 | 2015-01-28 | 株式会社ジェノミックス | 末梢循環への骨髄由来多能性幹細胞動員薬 |
| CN102076351A (zh) | 2008-04-30 | 2011-05-25 | 吉诺米克斯股份有限公司 | 损伤组织的功能性再生促进药物 |
| US9109206B2 (en) | 2009-10-16 | 2015-08-18 | Rutgers, The State University Of New Jersey | Method for treating chronic nerve tissue injury using a cell therapy strategy |
| KR20120135190A (ko) | 2009-10-28 | 2012-12-12 | 고꾸리쯔 다이가꾸 호우징 오사까 다이가꾸 | 골수 간엽계 및/또는 다능성 줄기세포의 혈중 동원(動員)에 의한 조직 재생 촉진제 |
| CN102443064A (zh) | 2011-11-03 | 2012-05-09 | 刘誉 | 一种基于凝血酶活性的双靶向作用的嵌合多肽及其应用 |
| DK2913059T3 (en) | 2012-10-25 | 2018-06-25 | Genomix Co Ltd | Hitherto UNKNOWN PROCEDURE FOR TREATMENT OF SPINE INJURY USING HMGB1 FRAGMENT |
| JP6253589B2 (ja) | 2012-10-25 | 2017-12-27 | 株式会社ジェノミックス | Ｈｍｇｂ１断片を利用した新規心筋梗塞の治療法 |
-
2012
- 2012-04-03 EP EP18160112.1A patent/EP3358011B1/en active Active
- 2012-04-03 CN CN201710265231.9A patent/CN107188948B/zh active Active
- 2012-04-03 CN CN202111352869.9A patent/CN114106139B/zh active Active
- 2012-04-03 EP EP12777041.0A patent/EP2703487B1/en active Active
- 2012-04-03 KR KR1020137031356A patent/KR101992807B1/ko active Active
- 2012-04-03 CN CN201280031164.XA patent/CN103687946B/zh active Active
- 2012-04-03 CA CA2834255A patent/CA2834255C/en active Active
- 2012-04-03 US US14/114,395 patent/US10364276B2/en active Active
- 2012-04-03 KR KR1020197017639A patent/KR102113809B1/ko active Active
- 2012-04-03 DK DK12777041.0T patent/DK2703487T3/en active
- 2012-04-03 DK DK18160112.1T patent/DK3358011T3/da active
- 2012-04-03 PL PL12777041T patent/PL2703487T3/pl unknown
- 2012-04-03 AU AU2012248676A patent/AU2012248676B2/en active Active
- 2012-04-03 PT PT12777041T patent/PT2703487T/pt unknown
- 2012-04-03 PL PL18160112T patent/PL3358011T3/pl unknown
- 2012-04-03 ES ES18160112T patent/ES2788394T3/es active Active
- 2012-04-03 JP JP2013511983A patent/JP6069191B2/ja active Active
- 2012-04-03 ES ES12777041.0T patent/ES2684718T3/es active Active
- 2012-04-03 WO PCT/JP2012/059113 patent/WO2012147470A1/ja not_active Ceased
- 2012-04-03 PT PT181601121T patent/PT3358011T/pt unknown
-
2016
- 2016-11-02 JP JP2016214996A patent/JP6336549B2/ja active Active
-
2017
- 2017-05-31 AU AU2017203644A patent/AU2017203644B9/en active Active
- 2017-08-30 US US15/691,017 patent/US10550165B2/en active Active
-
2018
- 2018-05-02 JP JP2018088729A patent/JP6603964B2/ja active Active
-
2019
- 2019-08-02 AU AU2019210647A patent/AU2019210647B2/en active Active
- 2019-09-26 JP JP2019175276A patent/JP2020058344A/ja active Pending
- 2019-12-13 US US16/713,202 patent/US20200369736A1/en not_active Abandoned
-
2021
- 2021-08-06 JP JP2021129955A patent/JP2021191271A/ja active Pending
-
2022
- 2022-03-18 AU AU2022201894A patent/AU2022201894B2/en active Active
- 2022-12-21 US US18/069,421 patent/US20230212241A1/en not_active Abandoned
-
2023
- 2023-05-23 JP JP2023084251A patent/JP2023106525A/ja active Pending